{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:46:55Z","timestamp":1784616415262,"version":"3.55.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013464","name":"National Drug Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.neuropharm.2019.107740","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T11:26:56Z","timestamp":1566214016000},"page":"107740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"special_numbering":"C","title":["Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms"],"prefix":"10.1016","volume":"167","author":[{"given":"Ewa","family":"Galaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Hua","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ju","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6482-8104","authenticated-orcid":false,"given":"Zheng-Xiong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.107740_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/adb.12495","article-title":"Cannabidiol reduces ethanol consumption, motivation and relapse in mice","volume":"23","author":"Viudez-Mart\u00ednez","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib2","first-page":"119","article-title":"The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats","volume":"60","author":"Adamczyk","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2012.01.030","article-title":"The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats","volume":"1444","author":"Adamczyk","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107740_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s002130100704","article-title":"Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens","volume":"155","author":"Andrews","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2019.107740_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2004.12.033","article-title":"The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens","volume":"508","author":"Andrews","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib6","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/npp.2012.22","article-title":"Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB\u2082 receptors","volume":"37","author":"Aracil-Fern\u00e1ndez","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107740_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pbb.2005.02.015","article-title":"The role of endocannabinoid transmission in cocaine addiction","volume":"81","author":"Arnold","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2019.107740_bib8","article-title":"Cannabidiol inhibits sucrose self-administration by Cb1 and CB2 receptor mechanism in rodents","author":"Bi","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bcp.2018.04.003","article-title":"Phyto and endocannabinoids exert complex actions on calcium and zinc signaling in mouse cortical neurons","volume":"152","author":"Bouron","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","article-title":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors","volume":"37","author":"Castillo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2019.107740_bib13","first-page":"1","article-title":"Chronic stimulation of the tone of endogenous anandamide reduces cue- and stress-induced relapse in rats","volume":"18","author":"Chauvet","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1037\/pha0000209","article-title":"Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys","volume":"26","author":"Collins","year":"2018","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2019.107740_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1037\/0735-7044.101.2.209","article-title":"Fitting intracranial self-stimulation data with growth models","volume":"2","author":"Coulombe","year":"1987","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107740_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02009","article-title":"Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age","volume":"9","author":"Crippa","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/cn300072u","article-title":"Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction","volume":"4","author":"Cunningham","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107740_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cpt1976193300","article-title":"Influence of cannabidiol on delta-9-tetrahydrocannabinol effects","volume":"19","author":"Dalton","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2019.107740_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/adb.12366","article-title":"Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats","volume":"22","author":"de Carvalho","year":"2017","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"De Gregorio","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2019.107740_bib21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm1001-1151","article-title":"A cannabinoid mechanism in relapse to cocaine seeking","volume":"7","author":"De Vries","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2019.107740_bib22","first-page":"269","article-title":"Attenuation of cocaine-induced conditioned place preference and motor activity via cannabinoid CB2 receptor agonism and CB1 receptor antagonism in rats","volume":"20","author":"Delis","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00370","article-title":"A personal retrospective: elevating anandamide (AEA) by targeting fatty acid amide hydrolase (FAAH) and the fatty acid binding proteins (FABPs)","volume":"7","author":"Deutsch","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib24","first-page":"77","article-title":"TRPV1 in the central nervous system: synaptic plasticity, function, and pharmacological implications","volume":"68","author":"Edwards","year":"2014","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.neuropharm.2019.107740_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fnmol.2017.00200","article-title":"Direct anandamide activation of TRPV1 produces divergent calcium and current responses","volume":"10","author":"Fenwick","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107740_bib26","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/sj.npp.1301509","article-title":"The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues","volume":"33","author":"Fletcher","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107740_bib27","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.neuron.2016.08.017","article-title":"Antipsychotic-like effects of M4 positive allosteric modulators are mediated by CB2 receptor-dependent inhibition of dopamine release","volume":"91","author":"Foster","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.107740_bib28","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Gaal","year":"2005","journal-title":"The Lancet"},{"key":"10.1016\/j.neuropharm.2019.107740_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neubiorev.2018.03.020","article-title":"Dopamine D1 and D3 receptor polypharmacology as a potential treatment approach for substance use disorder","volume":"89","author":"Galaj","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2019.107740_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2018.07.036","article-title":"Monoacylglycerol lipase (MAGL) as a promising therapeutic target","volume":"157","author":"Gil-Ord\u00f3\u00f1ez","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02245114","article-title":"Effects of buspirone and gepirone on i.v. cocaine self-administration in rhesus monkeys","volume":"108","author":"Gold","year":"1992","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2019.107740_bib32","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41386-018-0050-8","article-title":"Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle","volume":"43","author":"Gonzalez-Cuevas","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107740_bib33","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1177\/0269881118799954","article-title":"Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats","volume":"32","author":"Hay","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s13311-015-0373-7","article-title":"Early phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage","volume":"12","author":"Hurd","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2019.107740_bib35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/cn5000524","article-title":"Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability","volume":"5","author":"Iannotti","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107740_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2010.12.031","article-title":"Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors","volume":"490","author":"Ignatowska-Jankowska","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2019.107740_bib37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/syn.20714","article-title":"A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands","volume":"64","author":"Ishiguro","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2019.107740_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2018.12.026","article-title":"Progress in brain cannabinoid CB2 receptors: from gene to behavior","author":"Jordan","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2019.107740_bib39","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1073\/pnas.1711351114","article-title":"Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome","volume":"114","author":"Kaplan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.107740_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pnpbp.2017.08.022","article-title":"Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats","volume":"82","author":"Karimi-Haghighi","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107740_bib41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","article-title":"Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors","volume":"372","author":"Kathmann","year":"2006","journal-title":"Naunyn Schmied Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1369-1600.2012.00483.x","article-title":"Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus","volume":"18","author":"Katsidoni","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00213-013-3106-9","article-title":"Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans","volume":"229","author":"Keck","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2019.107740_bib44","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00213-009-1506-7","article-title":"The future of endocannabinoid-oriented clinical research after CB1 antagonists","volume":"205","author":"Le Foll","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107740_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MPA.0b013e318259f6f0","article-title":"Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice","volume":"42","author":"Li","year":"2013","journal-title":"Pancreas"},{"key":"10.1016\/j.neuropharm.2019.107740_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.09.043","article-title":"Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus","volume":"143","author":"Luj\u00e1n","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107740_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0269881116667706","article-title":"Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats","volume":"31","author":"Mahmud","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S2045796018000239","article-title":"Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview","volume":"27","author":"Mandolini","year":"2018","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.neuropharm.2019.107740_bib50","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bcp.2018.09.013","article-title":"Role of the endocannabinoid system in drug addiction","volume":"157","author":"Manzanares","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0043-117838","article-title":"Effects of cannabidiol on morphine conditioned place preference in mice","volume":"84","author":"Markos","year":"2018","journal-title":"Planta Med."},{"key":"10.1016\/j.neuropharm.2019.107740_bib52","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.neuropharm.2019.107740_bib53","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3389\/fphar.2017.00744","article-title":"Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors","volume":"8","author":"Mart\u00ednez-Pinilla","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/syn.10083","article-title":"Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation","volume":"45","author":"M\u00fcller","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2019.107740_bib55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/syn.20323","article-title":"Modification of cocaine-induced behavioral and neurochemical effects by serotonin1A receptor agonist\/antagonist in mice","volume":"60","author":"Nakamura","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2019.107740_bib56","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bcp.2018.08.046","article-title":"Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes","volume":"157","author":"Navarro","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib57","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bcp.2012.06.023","article-title":"Medication discovery for addiction: translating the dopamine D3 receptor hypothesis","volume":"84","author":"Newman","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib58","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/npp.2014.90","article-title":"Transient receptor potential vanilloid type 1 channel may modulate opioid reward","volume":"39","author":"Nguyen","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107740_bib59","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1038\/npp.2016.93","article-title":"Cannabidiol modulates fear memory formation through interactions with serotonergic transmission in the mesolimbic system","volume":"41","author":"Norris","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107740_bib60","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00213-004-1825-7","article-title":"Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats","volume":"175","author":"Parker","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2019.107740_bib61","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF02244643","article-title":"Effects of serotonergic manipulations on cocaine self-administration in rats","volume":"110","author":"Peltier","year":"1993","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2019.107740_bib62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib63","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107740_bib64","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1523\/JNEUROSCI.3387-15.2016","article-title":"Cannabidiol counteracts amphetamine-induced neuronal and behavioral sensitization of the mesolimbic dopamine pathway through a novel mTOR\/p70S6 kinase signaling pathway","volume":"36","author":"Renard","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107740_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2019.107740_bib66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnint.2018.00051","article-title":"Cannabis therapeutics and the future of neurology","volume":"12","author":"Russo","year":"2018","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107740_bib67","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2019.107740_bib68","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib69","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.clinthera.2018.07.020","article-title":"Cannabidiol for epilepsy: new hope on the horizon?","volume":"40","author":"Sanmartin","year":"2018","journal-title":"Clin. Ther."},{"key":"10.1016\/j.neuropharm.2019.107740_bib70","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41401-018-0075-x","article-title":"Brain activity of anandamide: a rewarding bliss?","volume":"40","author":"Scherma","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2019.107740_bib71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yebeh.2018.07.027","article-title":"Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: a randomized, double-blind, controlled trial","volume":"88","author":"Schoedel","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2019.107740_bib72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuropharm.2017.05.031","article-title":"The endocannabinoid system as a target for addiction treatment: trials and tribulations","volume":"124","author":"Sloan","year":"2017","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2019.107740_bib73","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/bph.14625","article-title":"Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats","volume":"176","author":"Spiller","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib74","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neuropharm.2017.07.024","article-title":"Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors","volume":"125","author":"Stern","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107740_bib75","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.phrs.2015.07.017","article-title":"Aiming for allosterism: evaluation of allosteric modulators of CB1 in a neuronal model","volume":"99","author":"Straiker","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2019.107740_bib76","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1073\/pnas.1211204110","article-title":"Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses","volume":"110","author":"Sylantyev","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2019.107740_bib77","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2019.107740_bib78","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/bph.14440","article-title":"Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors","volume":"176","author":"Tham","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib79","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.31.1_supplement.811.7","article-title":"The non-psychoactive phytocannabinoid, cannabidiol (CBD), and the synthetic derivatives, HU308 and CBD-DMH, reduces hyperalgesia and inflammation in a mouse model of corneal injury","volume":"31","author":"Thapa","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2019.107740_bib80","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib81","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0896-6273(00)80564-4","article-title":"The cloned capsaicin receptor integrates multiple pain-producing stimuli","volume":"21","author":"Tominaga","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.107740_bib82","doi-asserted-by":"crossref","first-page":"523418","DOI":"10.1155\/2015\/523418","article-title":"Cannabidiol rescues acute hepatic toxicity and seizure induced by cocaine","volume":"2015","author":"Vilela","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2019.107740_bib83","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1111\/bph.14380","article-title":"Effects of cannabidiol plus naloxone on motivation and ethanol consumption","volume":"175","author":"Viudez-Mart\u00ednez","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib84","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41401-018-0032-8","article-title":"Cannabidiol does not display drug abuse potential in mice behavior","volume":"40","author":"Viudez-Mart\u00ednez","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2019.107740_bib85","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drugalcdep.2009.07.002","article-title":"The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse","volume":"105","author":"Ward","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2019.107740_bib86","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1369-1600.2008.00109.x","article-title":"The role of CB1 receptors in psychostimulant addiction","volume":"13","author":"Wiskerke","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2019.107740_bib87","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-811X-8-12","article-title":"Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis","volume":"8","author":"Wolf","year":"2010","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.neuropharm.2019.107740_bib88","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1523\/JNEUROSCI.0726-06.2006","article-title":"Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens","volume":"26","author":"Xi","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107740_bib89","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.npp.1300912","article-title":"The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats","volume":"31","author":"Xi","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107740_bib90","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1301552","article-title":"Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats","volume":"33","author":"Xi","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107740_bib91","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nn.2874","article-title":"Brain cannabinoid CB\u2082 receptors modulate cocaine's actions in mice","volume":"14","author":"Xi","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107740_bib92","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/npp.2015.268","article-title":"5-HT1A autoreceptors in the dorsal raphe nucleus convey vulnerability to compulsive cocaine seeking","volume":"41","author":"You","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107740_bib93","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbr.2010.10.008","article-title":"Effects of cannabinoid CB\u2081 receptor antagonist rimonabant on acquisition and reinstatement of psychostimulant reward memory in mice","volume":"217","author":"Yu","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107740_bib94","doi-asserted-by":"crossref","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.107740_bib95","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/adb.12367","article-title":"Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats","volume":"22","author":"Zhang","year":"2017","journal-title":"Addict. Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819302990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819302990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:04:18Z","timestamp":1758438258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819302990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":95,"alternative-id":["S0028390819302990"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107740","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107740"}}